Russia expected to register second COVID-19 vaccine on Oct 15: Developer
The vaccine has been developed by Siberia's Vector Institute, which completed early-stage human trials of the vaccine last month.
By Reuters |
Agencies
MOSCOW: Russia is expected to register a second potential vaccine against COVID-19 on Oct. 15, the vaccine's developer said on Friday.
The vaccine has been developed by Siberia's Vector Institute, which completed early-stage human trials of the vaccine last month.
The vaccine has been developed by Siberia's Vector Institute, which completed early-stage human trials of the vaccine last month.
Download
The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.
The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
Related Articles
Scientists sceptical about Russia's Covid vaccine, cite lack of evidence for efficacyADVERTISEMENT
